FDA Investigator Qin Xu
Qin Xu has inspections in 9 countries as of 27 Oct 2023. Qin Xu has collaborated with a combinined 5425 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
61
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
China,
Germany,
Japan,
Spain,
United States of America,
Canada,
Thailand,
India,
Taiwan
Co-Investigator(s):
Aimee Cunningham, PhD,
Alan P Kurtzberg,
Alison N Stieg,
Amanda B Athey,
Anastasia I Offordile,
Anastasia I Onuorah,
Anastasia M Shields,
Anh M Lac,
Anita R Michael,
Anthony F Lorenzo,
Arie C Menachem,
Arsen Karapetyan,
Asamoah Asamoah,
Ashley L Reiber,
Atul J Agrawal,
Austin B Appler,
Azza Talaat,
Barbara Janine Breithaupt,
Bijoy Panicker,
Bonita S Chester,
Brandy N Lepage,
Brian L Belz,
Brian R Yaun,
Brian R Yuan,
Brooke K Higgins,
Brooke K Seeman,
Burnell M Henry,
Candice C Mandera,
Candice J Cortes,
Caroline Strasinger,
Carrie L Doupnik,
CDR Ileana Barreto Pettit,
Chaltu N Wakijra,
Charles I Ann,
Chiang Syin, PhD,
Chris A Sack,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christina K Theodorou,
Christopher T Middendorf,
Chryste D Best,
Clarice J Ahn,
Cody D Rickman,
Concepcion Cruz, Jr,
Conrad M Guardia,
Craig D Zagata,
Cynthia A Palmer,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Cynthia R Gibson,
Dale A Nyberg,
Dandan Wang, PhD,
Daniel J Deciero,
Daniel J Min,
Daryl A Dewoskin,
David A Oluwo,
David J Hafner,
Deborah J Parris,
Dell S Moller,
Denise M Digiulio,
Dennis Cantellops Paite,
Dennis L Doupnik,
Deyaa Shaheen,
Diane L Raccasi,
Diane T Bargo,
Diane T O'brien,
Dianne H Milazzo,
Dianne S Alexander,
Dipesh K Shah,
Djamila Harouaka,
Donald L Lech,
Dongping Dai, PhD,
Douglas A Campbell,
Douglas C Kovacs,
Dr. Chunchang Fang,
Dr. Gang Wang, PhD,
Dr. Guang Gao, PhD,
Dr. Ralph M Bernstein, PhD,
Edward D Mcdonald,
Edward P Potter,
Eileen A Liu,
Elizabeth D Connell,
Emest F Bizjak,
Eric L Dong, BS,
Erika V Butler,
Erin L Mcfiren,
Fabian Chaparro,
Fabian Nchaparro Rodriguez,
Farhana Khan,
Felix Maldonado,
Francis A Guidry,
Frank Wackes,
Gale L Glinecki,
Gam S Zamil,
Gavin T Cua,
Gayle S Lawson,
George J Flynn,
George Pyramides,
Gerald B Seaborn, Jr,
Geraldine D Sanders,
Gifford Whitehurst, Jr,
Guerlain Ulysse,
Gwyn G Dickinson,
Hala L Selby,
Haoheng Yan, PhD,
Helen Verdel,
Howard Anderson, PhD,
Israel Santiago, OCM,
Ivan E Reyes,
Ivy E Sweeney,
Jacqueline Mdiaz Albertini,
Jai P Singh,
Jaison J Eapen,
James M Mason,
James M Simpson,
James R Birkenstamm,
James W Leonette,
Jamie D Richardson,
Janet A Rajan,
Javier O Vega,
Jawaid Hamid,
Jeffery A Hangartner,
Jeffrey P Raimondi,
Jennifer L Huntington,
Jennifer Swisher, PhD,
Jessica L Pressley,
Jingbo Xiao,
Joanne E King,
Joey C West,
Joey V Quitania,
John Dan,
John P Mistler,
Johnna L Bleem,
Jonathan W Chapman,
Jose Acruz Gonzalez,
Jose E Melendez, DDC,
Jose M Cayuela,
Jose R Hernandez,
Joseph R Lambert,
Joseph W Matthews,
Joshua P Wireman,
Julie A Silberberg,
Junho Pak,
Justin A Boyd,
Kalavati Suvarna, PhD,
Kara D Dobbin,
Karen A Briggs,
Karen Takahashi,
Katelyn Astaub Zamperini,
Katherine E Jacobitz,
Katherine Szestypalow,
Kathleen M Jordan,
Keith M Reilly,
Kendra L Brooks,
Kenneth H Williams,
Kenneth Nieves,
Kham Phommachanh,
Ko U Min,
Kshitij A Patkar,
Latoya Oliver Powell,
Latoya S Oliver Powell,
Laurissa S Flowers,
Lawrence Harmon, Jr,
Lawrence J Stringer,
LCDR Debra Emerson,
LCDR Margaret E Digennaro,
Li Lu, PhD,
Lisa L Flores,
Lisa M Bellows,
Luella J Rossi,
Luis A Dasta,
Luis M Burgos Medero,
Luis Medero Burgos,
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret Faulkner,
Margaret H Waters,
Maria A Reed,
Maria Estrella,
Maria Joselopez Barragan, PhD,
Marian E Ramirez,
Marie F Morin,
Mark R Mcclain,
Marvin D Jones,
Massoud Motamed,
Matthew B Casale,
Matthew R Noonan,
Meisha Waters,
Melissa J Garcia,
Melissa T Roy,
Merideth K Rose,
Michael A Charles,
Michael L Casner,
Michael L Chasey,
Michael P Sheehan,
Michael R Klapal,
Michele L Obert,
Michele Perry Williams,
Michelle Marsh,
Mihaly S Ligmond,
Mra Davism,
Mra Greenc,
Muralidhara B Gavini, PhD,
Nancy G Schmidt,
Nancy L Rolli,
Nancy M Espinal,
Nawab A Siddiqui,
Nebil A Oumer,
Nicole E Knowlton,
Omotunde O Osunsanmi,
Pal S Mayasandra,
Paraluman S Leonin,
Parul Patel Sullivan,
Patricia H Dlugosz,
Patsy J Domingo,
Paul A Bonneau,
Paul L Bellamy,
Paula J Bretz,
Peter E Baker,
Pratik S Upadhyay, DDC,
Qiang Gui,
Rabin N Ghoshal,
Rachel C Harrington,
Ralph A Erickson,
Raymond D Kent,
Raymond T Oji,
Rebecca E Dombrowski,
Rebecca Parrilla,
Richard W Thornton,
Robert J Maffei,
Robert J Martin,
Robert L Lewis, Jr,
Robin Levis, PhD,
Rochelle L Cross,
Roger F Zabinski,
Rory K Geyer,
Rose M Ashley,
Rose Xu,
Ruark Lanham,
Russell J Glapion,
Saied A Asbagh,
Saleem A Akhtar,
Sam Pepe,
Sandra A Hughes,
Sangeeta M Khurana, PhD,
Sarah E Mcmullen,
Scott T Ballard,
Sean R Marcsisin,
Sena G Dissmeyer,
Shirley J Berryman,
Simone E Pitts,
Sixto M Mercado Rios,
Sneha Patel,
Sneha S Patel,
Stacey A Priest,
Stacie A Woods,
Stephanie L Shapley,
Stephen D Brown,
Steven Fong, MS, PhD,
Steven J Thurber,
Steven Kozlowski, MD,
Steven P Donald,
Sue Lee Chan,
Susan M Jackson,
Susan W Ting,
Susanna E Ford, Analyst,
Suzanne M Healy,
Suzanne M Muchene,
Suzanne Suzanne,
Swati Verma,
Tamika White,
Tamil Arasu, PhD,
Temar Q Williams,
Thai D Truong,
Thomas J Arista,
Thomas R Withers,
Tiffani D Wilson,
Timothy M Albright,
Timothy T Kapsala,
Tonia F Bernard,
Torrance J Slayton,
Toyin B Oladimeji,
Truong Xuan Nguyen (Andy),
Unnee Ranjan,
Upendra Paudel,
Uttaniti Limchumroon (Tom),
Vesna V Stanoyevitch,
Viviana Matta,
Vlada Matusovsky,
William A Warnick,
William J Leonard,
William L Bargo,
Xiandong Meng,
Xiaokuang Lai, PhD,
Xu Michael Di, PhD,
Yan Qin,
Yasamin Ameri,
Yumi J Hiramine,
Yvins Dezan,
Zakaria I Ganiyu,
Zedong Dong,
Zhao Wang, PhD,
Zhong Li, PhD,
Zhongren Wu
Qin Xu's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| October, 2015 | FDA 483 | Valgene Incorporated dba Cape Drugs - Form 483, 2015-10-07 |
| April, 2015 | FDA 483 | Mylan Pharmaceuticals Inc. - Form 483, 2015-04-24 |
| June, 2019 | FDA 483 | Intellipharmaceutics Corp. - Form 483, 2019-06-14 |
| July, 2015 | FDA 483 | Alkem Laboratories Limited - Form 483, 2015-07-31 |
| January, 2018 | FDA 483 | GP Grenzach Produktions GmbH - Form 483, 2018-01-30 |
| September, 2019 | FDA 483 | C-Care LLC - Form 483, 2019-09-16 |
| November, 2018 | EIR | Colgate-Palmolive (Thailand) Limited - Branch - EIR, 2018-11-16 |
| April, 2015 | EIR | Mylan Pharmaceuticals Inc. - EIR, 2015-04-24 |
| December, 2016 | FDA 483 | Kowa Company, Ltd. - Form 483, 2016-12-09 |
| August, 2018 | FDA 483 Response | AstraZeneca Pharmaceuticals LP - Form 483R, 2018-08-29 |
| July, 2016 | FDA 483 | Eisai Inc. - Form 483, 2016-07-22 |
| August, 2018 | FDA 483 | AstraZeneca Pharmaceuticals LP - Form 483, 2018-08-17 |
| July, 2015 | FDA 483 | Viyash Life Sciences Private Limited - Form 483, 2015-07-17 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more